PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - S3 Intermediate

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1074 participants.

Also called NCT03222128

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,074 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03222128
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03222128. Allocation not applicable; no masking; primary purpose treatment. Start 2014-02-17 (actual); primary completion 2015-11-18 (actual). Results posted on 2018-08-14.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - S3 Intermediate
Acronym
PII S3i
Condition
Symptomatic Severe Aortic Stenosis
Lead sponsor
Edwards Lifesciences (class: industry)

Record details

Record id
cardio:ct-nct03222128
Content hash
a43e5df7f616e99580e62a0c0e2bf225bec3d92ff6b5237ba8404d9512902296